论文部分内容阅读
目的:探讨在小儿毛细支气管炎患者中,应用普米克令舒治疗方案的临床疗效。方法:选取我院收治的小儿毛细支气管炎患者进行分析,将其随机分为对照组和观察组。对照组采用常规治疗方案,观察组在此基础上加用普米克令舒进行治疗,观察两组患者的临床治疗效果,以及不良反应发生情况。结果:观察组治疗有效率(93.8%)明显高于对照组(71.9%),患者止咳时间、平喘时间、哮鸣音消失时间、心率恢复正常时间均短于对照组,差异具有统计学意义(P<0.05)。观察组不良反应发生率为15.6%,对照组为12.5%,两组差异不大,不具有统计学意义(P>0.05)。结论:在小儿毛细支气管炎患者中,应用普米克令舒进行治疗的临床疗效更佳,能够显著缩短各项症状的恢复时间,减轻患者痛苦,且不良反应发生较少,值得临床推广。
Objective: To investigate the clinical efficacy of Pulmicort rescuing in pediatric patients with bronchiolitis. Methods: Children with bronchiolitis treated in our hospital were selected and analyzed. They were randomly divided into control group and observation group. In the control group, the conventional treatment was used. On the basis of this, the observation group was treated with pulmicort and the clinical effects and the incidence of adverse reactions were observed. Results: The effective rate (93.8%) in the observation group was significantly higher than that in the control group (71.9%). The duration of cough relief, antiasthmatic time, disappearance of wheeze, and normal heart rate recovery time in the observation group were shorter than those in the control group (P <0.05). The incidence of adverse reactions in the observation group was 15.6% and that in the control group was 12.5%. There was no significant difference between the two groups (P> 0.05). Conclusion: In children with bronchiolitis, the application of pulmicorts in the treatment of better clinical efficacy, can significantly reduce the recovery time of symptoms, reduce patient pain, and fewer adverse reactions, is worth clinical promotion.